Secondary degeneration reduced by inosine after spinal cord injury in rats

[1]  Csaba Szabó,et al.  Immunomodulatory and neuroprotective effects of inosine. , 2004, Trends in pharmacological sciences.

[2]  S. You,et al.  Neuroprotective effect of inosine on axotomized retinal ganglion cells in adult rats. , 2004, Investigative ophthalmology & visual science.

[3]  S. You,et al.  Significance of Fixation of the Vertebral Column for Spinal Cord Injury Experiments , 2003, Spine.

[4]  S. You,et al.  Effects of inosine on axonal regeneration of axotomized retinal ganglion cells in adult rats , 2003, Neuroscience Letters.

[5]  B. Kolb,et al.  Inosine induces axonal rewiring and improves behavioral outcome after stroke , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[6]  S. You,et al.  Direct protection of inosine on PC12 cells against zinc-induced injury , 2002, Neuroreport.

[7]  K. Murthy,et al.  Anti-inflammatory effects of inosine in human monocytes, neutrophils and epithelial cells in vitro. , 2001, International journal of molecular medicine.

[8]  M. Fehlings,et al.  Oligodendroglial apoptosis occurs along degenerating axons and is associated with FAS and p75 expression following spinal cord injury in the rat , 2001, Neuroscience.

[9]  C. Szabó,et al.  Purines inhibit poly(ADP‐ribose) polymerase activation and modulate oxidant‐induced cell death , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[10]  Jike Lu,et al.  Advances in Secondary Spinal Cord Injury: Role of Apoptosis , 2000, Spine.

[11]  C. Szabó,et al.  Inosine Inhibits Inflammatory Cytokine Production by a Posttranscriptional Mechanism and Protects Against Endotoxin-Induced Shock1 , 2000, The Journal of Immunology.

[12]  J. Madsen,et al.  Inosine stimulates extensive axon collateral growth in the rat corticospinal tract after injury. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[13]  A. Amar,et al.  Pathogenesis and pharmacological strategies for mitigating secondary damage in acute spinal cord injury. , 1999, Neurosurgery.

[14]  J. H. Lucas,et al.  Inosine and guanosine preserve neuronal and glial cell viability in mouse spinal cord cultures during chemical hypoxia , 1999, Brain Research.

[15]  L. Benowitz,et al.  Axon Outgrowth Is Regulated by an Intracellular Purine-sensitive Mechanism in Retinal Ganglion Cells* , 1998, The Journal of Biological Chemistry.

[16]  H. Koprowski,et al.  Uric acid, a natural scavenger of peroxynitrite, in experimental allergic encephalomyelitis and multiple sclerosis. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[17]  John Calvin Reed,et al.  Differential Regulation of Bax, Bcl‐2, and Bcl‐X Proteins in Focal Cortical Ischemia in the Rat , 1998, Brain pathology.

[18]  M. Jacquin,et al.  Neuronal and Glial Apoptosis after Traumatic Spinal Cord Injury , 1997, The Journal of Neuroscience.

[19]  H. Winn,et al.  Administration of Methylprednisolone for 24 or 48 Hours or Tirilazad Mesylate for 48 Hours in the Treatment of Acute Spinal Cord Injury Results of the Third National Acute Spinal Cord Injury Randomized Controlled Trial , 1997 .

[20]  G. Johnson,et al.  Pretreatment with NMDA receptor antagonist MK801 improves neurophysiological outcome after an acute spinal cord injury. , 1996, Neurological research.

[21]  L. Horrocks,et al.  Inosine Mediates the Protective Effect of Adenosine in Rat Astrocyte Cultures Subjected to Combined Glucose‐Oxygen Deprivation , 1996, Journal of neurochemistry.

[22]  H. Manev,et al.  Pharmacological characterization of apoptotic cell death in a model of photothrombotic brain injury in rats , 1996, Brain Research.

[23]  M. Schwab,et al.  Degeneration and regeneration of axons in the lesioned spinal cord. , 1996, Physiological reviews.

[24]  B. Kraupp,et al.  In situ detection of fragmented dna (tunel assay) fails to discriminate among apoptosis, necrosis, and autolytic cell death: A cautionary note , 1995, Hepatology.

[25]  C H Tator,et al.  Review of the secondary injury theory of acute spinal cord trauma with emphasis on vascular mechanisms. , 1991, Journal of neurosurgery.

[26]  W. Collins,et al.  A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury. Results of the Second National Acute Spinal Cord Injury Study. , 1991, The New England journal of medicine.

[27]  M. Bracken.  Methylprednisolone in the management of acute spinal cord injuries , 1990, The Medical journal of Australia.

[28]  Lingzhi Fan,et al.  The glucose oxidase-DAB-nickel method in peroxidase histochemistry of the nervous system , 1988, Neuroscience Letters.

[29]  B. Green,et al.  Efficacy of methylprednisolone in acute spinal cord injury. , 1984, JAMA.

[30]  Balentine Jd.  Pathology of experimental spinal cord trauma. I. The necrotic lesion as a function of vascular injury. , 1978 .

[31]  H. Winn,et al.  Administration of methylprednisolone for 24 or 48 hours or tirilazad mesylate for 48 hours in the treatment of acute spinal cord injury. Results of the Third National Acute Spinal Cord Injury Randomized Controlled Trial. National Acute Spinal Cord Injury Study. , 1997, JAMA.

[32]  J. Bresnahan,et al.  Apoptosis and delayed degeneration after spinal cord injury in rats and monkeys , 1997, Nature Medicine.

[33]  F. Geisler,et al.  Correction: recovery of motor function after spinal-cord injury--a randomized, placebo-controlled trial with GM-1 ganglioside. , 1991, The New England journal of medicine.

[34]  C. Hsu,et al.  Methylprednisolone in spinal cord injury: the possible mechanism of action. , 1990, Journal of neurotrauma.